CHICAGO — It took less than two weeks into 2020 for cannabidiol (CBD) to generate more buzz. On Jan. 13, a bipartisan group of lawmakers introduced a bill that would amend the Federal Food, Drug and Cosmetic Act to include CBD in the definition of dietary supplements, which would allow the ingredient to be marketed in food, beverages and nutritional supplements.
The new bill addresses the U.S. Food & Drug Administration’s (FDA's) oversight of CBD and also laws regarding hemp cultivation oversight by the U.S. Department of Agriculture (USDA). It would require the USDA to study “regulatory and market barriers for farmers engaged in hemp production,” specifically the costs of implementing hemp testing programs, the costs of destroying hemp that exceeds the THC limit, the feasibility of the required testing timeline and “other known or potential challenges.”
- Click here to download CSP's 2020 CBD Category Digest, created in partnership with Floyd's of Leadville.
The bill wasn’t the only CBD-related news that stole headlines. Here’s a compilation of the latest news stories relating to the budding product ingredient …
Inside the company’s plans for cannabidiol in 2020 and lessons learned so far
A rundown of the potential risks
How store operators can navigate the murky waters
State senators want to create more regulations on who is allowed to sell glass and metal pipes
Each piece of the mint-flavored gum contains 10 milligrams of CBD
CBD companies from Canada are expected to compete with U.S. brands